Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial

BACKGROUND: Women with hereditary angioedema due to C1-inhibitor deficiency (HAE-C1INH) experience more frequent and severe angioedema attacks compared with men. Fluctuations in female sex hormones can influence HAE attack frequency and severity. Subcutaneous C1-INH (C1-INH [SC]) is indicated as rou...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, Donald S., Farkas, Henriette, Riedl, Marc A., Hsu, Florence Ida, Brooks, Joel P., Cicardi, Marco, Feuersenger, Henrike, Pragst, Ingo, Reshef, Avner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001333/
https://www.ncbi.nlm.nih.gov/pubmed/32042283
http://dx.doi.org/10.1186/s13223-020-0409-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001333/
https://www.ncbi.nlm.nih.gov/pubmed/32042283
http://dx.doi.org/10.1186/s13223-020-0409-3

Ejemplares similares